1. Home
  2. OTH vs DXR Comparison

OTH vs DXR Comparison

Compare OTH & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OTH

Off The Hook YS Inc.

N/A

Current Price

$2.45

Market Cap

67.2M

Sector

Industrials

ML Signal

N/A

Logo Daxor Corporation

DXR

Daxor Corporation

N/A

Current Price

$10.31

Market Cap

71.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OTH
DXR
Founded
2012
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.2M
71.4M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
OTH
DXR
Price
$2.45
$10.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.0K
12.7K
Earning Date
12-15-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,446,345.00
Revenue This Year
N/A
$44,935.22
Revenue Next Year
N/A
$74.79
P/E Ratio
$600.18
$33.83
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$7.10
52 Week High
$3.75
$14.76

Technical Indicators

Market Signals
Indicator
OTH
DXR
Relative Strength Index (RSI) 51.13 25.51
Support Level $2.03 $10.00
Resistance Level $2.72 $10.49
Average True Range (ATR) 0.28 0.40
MACD -0.02 -0.07
Stochastic Oscillator 66.67 10.78

Price Performance

Historical Comparison
OTH
DXR

About OTH Off The Hook YS Inc.

Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: